ALLR 8-K 2026-09-29

Allarity Therapeutics, Inc. (ALLR) 8-K dated 2026-09-29 — accession 0001213900-26-104317. This URL is the filing, not the ALLR hub.

Allarity Therapeutics, Inc. (ALLR) is a biotechnology company listed on US.

Allarity Therapeutics, Inc. filed a 8-K on 2026-09-29. Accession 0001213900-26-104317.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ALLR revenue for 2025-12-31 was $320.0K. Net income was -$11.2M. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.

Not investment advice. The ALLR SEC hub lists recent forms. The stock page is the research view.